Dynamic quotes: Off
|
ETFs with PFE as a Top 10 Holding*Sponsored by:
| Weighting | ETF Name (Symbol) | 100-Day Price Change (%) |
|---|---|---|
| 11.75% | Select Sector SPDR Fund - Health Care (XLV) | +9.44 (23.69%) |
| 11.04% | iShares Dow Jones U.S. Health Care Index Fund (IYH) | +20.92 (25.36%) |
| 10.98% | Merrill Lynch Pharmaceutical HOLDRS (PPH) | +8.03 (20.41%) |
| 10.24% | Vanguard Health Care ETF (VHT) | +16.93 (23.67%) |
| 9.69% | iShares Dow Jones U.S. Pharmaceutical Index Fund (IHE) | +18.79 (22.37%) |
|
||
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Pfizer Inc. is a research-based, global biopharmaceutical company. We apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as many of the world’s best-known consumer products. Every day, we work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We also collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. ... More ...
Consensus Recommendation |
|
Analyst Info |
|
| Annual EPS Est: | $2.19 |
| Quarterly EPS Est: | 0.57 |
| PEG Ratio: | 2.98 |
|
Mean Recommendation: View Summary / View All |
1.25 |
Data is provided by Zacks Investment Research